相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate Cancer
Brandon A. Mahal et al.
EUROPEAN UROLOGY (2018)
Validation of a 10-gene molecular signature for predicting biochemical recurrence and clinical metastasis in localized prostate cancer
Hatem Abou-Ouf et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: Preliminary findings
Rakesh Shiradkar et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2018)
Comparison of cell cycle progression score with two immunohistochemical markers (PTEN and Ki-67) for predicting outcome in prostate cancer after radical prostatectomy
Priscilla Leon et al.
WORLD JOURNAL OF UROLOGY (2018)
Metabolomic Prediction of Human Prostate Cancer Aggressiveness: Magnetic Resonance Spectroscopy of Histologically Benign Tissue
Lindsey A. Vandergrift et al.
SCIENTIFIC REPORTS (2018)
PSCA, Cox-2, and Ki-67 are independent, predictive markers of biochemical recurrence in clinically localized prostate cancer: a retrospective study
Sung Han Kim et al.
ASIAN JOURNAL OF ANDROLOGY (2017)
Androgen receptor (AR) positive vs negative roles in prostate cancer cell deaths including apoptosis, anoikis, entosis, necrosis and autophagic cell death
Simeng Wen et al.
CANCER TREATMENT REVIEWS (2014)
Overdetection of Recurrence after Radical Prostatectomy: Estimates Based on Patient and Tumor Characteristics
Jing Xia et al.
CLINICAL CANCER RESEARCH (2014)
Extra-telomeric Functions of Human Telomerase: Cancer, Mitochondria and Oxidative Stress
G. Saretzki
CURRENT PHARMACEUTICAL DESIGN (2014)
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
Emilie Lalonde et al.
LANCET ONCOLOGY (2014)
Differences in the expression of telomerase and prostate-specific membrane antigen in non-advanced prostatic cancer
Anna Gasinska et al.
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA (2013)
MICROVESSEL DENSITY AND EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN CLINICALLY LOCALIZED PROSTATE CANCER
Elzbieta Luczynska et al.
POLISH JOURNAL OF PATHOLOGY (2013)
Diagnostic and prognostic molecular biomarkers for prostate cancer
Glen Kristiansen
HISTOPATHOLOGY (2012)
EXPRESSION OF KI-67 (MIB-1) AND GLUT-1 PROTEINS IN NON-ADVANCED PROSTATIC CANCER
Elzbieta Luczynska et al.
POLISH JOURNAL OF PATHOLOGY (2012)
High Level PSMA Expression Is Associated With Early PSA Recurrence in Surgically Treated Prostate Cancer
Sarah Minner et al.
PROSTATE (2011)
Contemporary Risk Profile of Prostate Cancer in the United States
Yu-Hsuan Shao et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Wild-type but not mutant androgen receptor inhibits expression of the hTERT telomerase subunit: a novel role of AR mutation for prostate cancer development
Udo Moehren et al.
FASEB JOURNAL (2008)
Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress
Shaheda Ahmed et al.
JOURNAL OF CELL SCIENCE (2008)
Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study
Roy Vergis et al.
LANCET ONCOLOGY (2008)
Hypoxia-inducible factors: central regulators of the tumor phenotype
John D. Gordan et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2007)
Radical prostatectomy versus watchful waiting in early prostate cancer
A Bill-Axelson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: Long-term results
KA Roehl et al.
JOURNAL OF UROLOGY (2004)
Microvessel density as a predictor of PSA recurrence after radical prostatectomy - A comparison of CD34 and CD31
A de la Taille et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2000)
分享论文
